Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia

BACKGROUND Recent advances have enabled noninvasive mapping of cardiac arrhythmias with electrocardiographic imaging and noninvasive delivery of precise ablative radiation with stereotactic body radiation therapy (SBRT). We combined these techniques to perform catheter‐free, electrophysiology‐guided, noninvasive cardiac radioablation for ventricular tachycardia. METHODS We targeted arrhythmogenic scar regions by combining anatomical imaging with noninvasive electrocardiographic imaging during ventricular tachycardia that was induced by means of an implantable cardioverter–defibrillator (ICD). SBRT simulation, planning, and treatments were performed with the use of standard techniques. Patients were treated with a single fraction of 25 Gy while awake. Efficacy was assessed by counting episodes of ventricular tachycardia, as recorded by ICDs. Safety was assessed by means of serial cardiac and thoracic imaging. RESULTS From April through November 2015, five patients with high‐risk, refractory ventricular tachycardia underwent treatment. The mean noninvasive ablation time was 14 minutes (range, 11 to 18). During the 3 months before treatment, the patients had a combined history of 6577 episodes of ventricular tachycardia. During a 6‐week postablation “blanking period” (when arrhythmias may occur owing to postablation inflammation), there were 680 episodes of ventricular tachycardia. After the 6‐week blanking period, there were 4 episodes of ventricular tachycardia over the next 46 patient‐months, for a reduction from baseline of 99.9%. A reduction in episodes of ventricular tachycardia occurred in all five patients. The mean left ventricular ejection fraction did not decrease with treatment. At 3 months, adjacent lung showed opacities consistent with mild inflammatory changes, which had resolved by 1 year. CONCLUSIONS In five patients with refractory ventricular tachycardia, noninvasive treatment with electrophysiology‐guided cardiac radioablation markedly reduced the burden of ventricular tachycardia. (Funded by Barnes–Jewish Hospital Foundation and others.)

[1]  Dhanunjaya R. Lakkireddy,et al.  Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease. , 2017, Journal of the American College of Cardiology.

[2]  K. D. Parker,et al.  Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams , 2016, Scientific Reports.

[3]  Y. Rudy,et al.  Electrophysiologic Scar Substrate in Relation to VT: Noninvasive High‐Resolution Mapping and Risk Assessment with ECGI , 2016, Pacing and clinical electrophysiology : PACE.

[4]  C. Criscitiello,et al.  Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management , 2016, CA: a cancer journal for clinicians.

[5]  John L Sapp,et al.  Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. , 2016, The New England journal of medicine.

[6]  F. Marchlinski,et al.  Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial. , 2016, Journal of the American College of Cardiology.

[7]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[8]  Sanghamitra Mohanty,et al.  Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial. , 2015, Journal of the American College of Cardiology.

[9]  Dhanunjaya R. Lakkireddy,et al.  Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. , 2015, Heart rhythm.

[10]  R. Ruiz-Granell,et al.  Endo-Epicardial Versus Only-Endocardial Ablation as a First Line Strategy for the Treatment of Ventricular Tachycardia in Patients With Ischemic Heart Disease , 2015, Circulation. Arrhythmia and electrophysiology.

[11]  W. Stevenson,et al.  Role of Alternative Interventional Procedures When Endo- and Epicardial Catheter Ablation Attempts for Ventricular Arrhythmias Fail , 2015, Circulation. Arrhythmia and electrophysiology.

[12]  Paul C. Zei,et al.  Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. , 2015, Circulation. Arrhythmia and electrophysiology.

[13]  M. Haissaguerre,et al.  Substrate Mapping and Ablation for Ventricular Tachycardia: The LAVA Approach , 2015, Journal of cardiovascular electrophysiology.

[14]  F. Marchlinski,et al.  Core Isolation of Critical Arrhythmia Elements for Treatment of Multiple Scar-Based Ventricular Tachycardias , 2015, Circulation. Arrhythmia and electrophysiology.

[15]  A. Verma,et al.  Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  Elena Arbelo,et al.  Scar Dechanneling: New Method for Scar-Related Left Ventricular Tachycardia Substrate Ablation , 2015, Circulation. Arrhythmia and electrophysiology.

[17]  M. Branny,et al.  Cardiac Radiosurgery for Malignant Ventricular Tachycardia , 2014 .

[18]  G. Hindricks,et al.  Outcomes in Catheter Ablation of Ventricular Tachycardia in Dilated Nonischemic Cardiomyopathy Compared With Ischemic Cardiomyopathy: Results From the Prospective Heart Centre of Leipzig VT (HELP-VT) Study , 2014, Circulation.

[19]  W. Stevenson,et al.  Acute Failure of Catheter Ablation for Ventricular Tachycardia Due to Structural Heart Disease: Causes and Significance , 2013, Journal of the American Heart Association.

[20]  Nicholas Ayache,et al.  Integration of Merged Delayed‐Enhanced Magnetic Resonance Imaging and Multidetector Computed Tomography for the Guidance of Ventricular Tachycardia Ablation: A Pilot Study , 2013, Journal of cardiovascular electrophysiology.

[21]  Sanghamitra Mohanty,et al.  Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[22]  Y. Rudy,et al.  The electrophysiological cardiac ventricular substrate in patients after myocardial infarction: noninvasive characterization with electrocardiographic imaging. , 2011, Journal of the American College of Cardiology.

[23]  B. Lindsay,et al.  Noninvasive Electroanatomic Mapping of Human Ventricular Arrhythmias with Electrocardiographic Imaging , 2011, Science Translational Medicine.

[24]  Timm Dickfeld,et al.  MRI-Guided Ventricular Tachycardia Ablation: Integration of Late Gadolinium-Enhanced 3D Scar in Patients With Implantable Cardioverter-Defibrillators , 2011, Circulation. Arrhythmia and electrophysiology.

[25]  S. Yusuf,et al.  Radiation-Induced Heart Disease: A Clinical Update , 2011, Cardiology research and practice.

[26]  M. Schell,et al.  Stereotactic body radiation therapy: the report of AAPM Task Group 101. , 2010, Medical physics.

[27]  Arjun D. Sharma,et al.  Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. , 2010, Heart rhythm.

[28]  Warren M. Jackman,et al.  Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction: The Multicenter Thermocool Ventricular Tachycardia Ablation Trial , 2008, Circulation.

[29]  Y. Rudy,et al.  Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia , 2004, Nature Medicine.